34.86

1.81% 0.62

Newamsterdam Pharma Company Nv (NAMS)

Overview News Price History Financials Why NAMS Down? Discussions Forecast

Newamsterdam Pharma Company Nv stock is traded at $34.86, with a volume of 443.67K. It is up +1.81% in the last 24 hours and up +6.64% over the past month. NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Previous Close:

$34.24

Open:

$34.26

24h Volume:

443.67K

Relative Volume:

0.52

Market Cap:

$3.95B

Revenue:

$14.09M

Net Income/Loss:

$-176.94M

P/E Ratio:

-16.21

EPS:

-2.15

Net Cash Flow:

$-141.24M

1W Performance:

+8.73%

1M Performance:

+6.64%

6M Performance:

+39.44%

1Y Performance:

+79.97%

1-Day Range:

$34.10

$35.62

1-Week Range:

$32.15

$35.62

52-Week Range:

$14.06

$42.00

Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile

Name

Newamsterdam Pharma Company Nv

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

35 206 2971

Address

GOOIMEER 2-35, NARRDEN

Employee

Twitter

Next Earnings Date

Latest SEC Filings

NAMS's Discussions on Twitter

Compare NAMS vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NAMS Newamsterdam Pharma Company Nv	34.86	3.88B	14.09M	-176.94M	-141.24M	-2.15
VRTX Vertex Pharmaceuticals Inc	465.02	117.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.65	82.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	833.54	51.64B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	308.48	42.58B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.42	38.87B	4.98B	69.60M	525.67M	0.5198

Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Resumed	H.C. Wainwright	Buy
Aug-25-25	Initiated	Wells Fargo	Overweight
Jul-17-25	Initiated	Goldman	Neutral
Jun-17-25	Initiated	Citigroup	Buy
Jun-10-25	Initiated	Stifel	Buy
Jun-04-25	Initiated	Cantor Fitzgerald	Overweight
Dec-30-24	Initiated	H.C. Wainwright	Buy
May-15-24	Initiated	TD Cowen	Buy
Mar-14-24	Initiated	Scotiabank	Sector Outperform
Jan-18-24	Initiated	Guggenheim	Buy
Jan-16-24	Initiated	Piper Sandler	Overweight
Oct-30-23	Initiated	RBC Capital Mkts	Outperform

View All

Newamsterdam Pharma Company Nv Stock (NAMS) Latest News

Feb 09, 2026

Momentum Shift: Should I trade or invest in NewAmsterdam Pharma Company NV2025 Support & Resistance & Reliable Momentum Entry Alerts - baoquankhu1.vn

Feb 09, 2026

Feb 07, 2026

Breakouts Watch: Will NewAmsterdam Pharma Company NV benefit from sector rotationBond Market & Fast Gain Stock Tips - baoquankhu1.vn

Feb 07, 2026

Feb 06, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 06, 2026

Keybank National Association OH Acquires New Stake in NewAmsterdam Pharma Company N.V. $NAMS - Defense World

Feb 06, 2026

Feb 04, 2026

NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit - The Manila Times

Feb 04, 2026

Understanding Momentum Shifts in (NAMS) - Stock Traders Daily

Feb 04, 2026

Feb 03, 2026

NewAmsterdam Pharma (NAMS) Stock Analysis: Healthcare Innovator with 54% Potential Upside - DirectorsTalk Interviews

Feb 03, 2026

Feb 02, 2026

Published on: 2026-02-02 19:49:09 - baoquankhu1.vn

Feb 02, 2026

Feb 01, 2026

Aug Highlights: Should I trade or invest in NewAmsterdam Pharma Company NV2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - baoquankhu1.vn

Feb 01, 2026

Atle Fund Management AB Purchases 36,402 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

Feb 01, 2026

Jan 31, 2026

Louise Frederika Kooij Sells 39,816 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock - Defense World

Jan 31, 2026

Buyback Watch: What are the risks of holding NewAmsterdam Pharma Company NV Equity WarrantJuly 2025 WrapUp & Weekly High Momentum Picks - baoquankhu1.vn

Jan 31, 2026

Take Profit: Can NewAmsterdam Pharma Company NV benefit from deglobalizationJuly 2025 Selloffs & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Jan 31, 2026

Jan 30, 2026

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 30, 2026

Jan 29, 2026

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Louise Frederika Kooij Sells 39,816 Shares of Stock - MarketBeat

Jan 29, 2026

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells $1,037,061.60 in Stock - MarketBeat

Jan 29, 2026

Will NewAmsterdam Pharma Company N.V. stock recover after earningsWeekly Trade Report & Capital Protection Trading Alerts - mfd.ru

Jan 29, 2026

(NAMSW) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Jan 29, 2026

Jan 28, 2026

Is NewAmsterdam Pharma Company N.V.’s ROIC above industry averageEarnings Growth Summary & Step-by-Step Swing Trade Plans - mfd.ru

Jan 28, 2026

Jan 27, 2026

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Louise Frederika Kooij Sells 38,172 Shares of Stock - MarketBeat

Jan 27, 2026

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Gem With 52% Upside Potential - DirectorsTalk Interviews

Jan 27, 2026

Jan 26, 2026

Bond Watch: Is ACOG a good ESG investment2025 Market Sentiment & Community Consensus Stock Picks - baoquankhu1.vn

Jan 26, 2026

Quarterly Recap: Is ESLT benefiting from innovation trendsTake Profit & Weekly Top Stock Performers List - baoquankhu1.vn

Jan 26, 2026

Jan 24, 2026